Globe iconLogin iconRecap iconSearch iconTickets icon

2020 Minor League drug suspensions

Players who violated MiLB Drug Prevention, Treatment Program
January 17, 2020

Players who violate the Minor League Drug Prevention and Treatment Program are subject to suspensions from the Office of the Commissioner of Baseball. Players who test positive for a banned performance-enhancing substance or test positive twice for a drug of abuse (definition updated Dec. 12, 2019) can receive suspensions as well as

Players who violate the Minor League Drug Prevention and Treatment Program are subject to suspensions from the Office of the Commissioner of Baseball. Players who test positive for a banned performance-enhancing substance or test positive twice for a drug of abuse (definition updated Dec. 12, 2019) can receive suspensions as well as players who refuse to take a drug test.
Suspensions are announced by the Office of the Commissioner of Baseball. Major League Baseball handed out 51 drug-related suspensions in 2019, 75 in 2018, 87 in 2017, 100 in 2016, 108 in 2015, 63 in 2014, 60 in 2013 and 105 in 2012.

Minor League suspensions in 2020
Jan 17: RHP Justin Lawrence* (COL) suspended 80 games for positive test of Dehydrochlormethyltestosterone
Feb. 19: INF/OF Pablo Reyes (PIT) suspended 80 games for positive test of Boldenone
Feb 21: C Edward Guzman (CIN) suspended 50 games for positive test of Amphetamine
Feb 21: RHP Kyle Hill (SEA) suspended 50 games for positive test for Amphatamine
Feb 21: OF Ryan Shinn (NYM) suspended 50 games for positive test for Ritalinic Acid
March 6: INF Domingo Leyba* (ARI) suspended 80 games for positive test for Boldenone
*-- suspended under MLB program as member of 40-man roster